Key result
Circulating lipoproteins act as proinflammatory and anti-inflammatory particles in atherogenesis.
Broadens view of lipoproteins in vascular inflammation; leaves open targeted therapies pending higher-level evidence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kovanen et al. (2003) conducted a review in Atherogenesis. Circulating lipoproteins was evaluated. Circulating lipoproteins act as proinflammatory and anti-inflammatory particles in atherogenesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: